0 Évaluations
ID

41618

Description

Study Title: LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients https://leoss.net Study Indication: COVID-19 Date: 14.10.2020, 15:07:14 Published with permission by Prof. Dr. med. J.-J. Vehreschild. LEOSS is mandated by the ESCMID Emerging Infections Task Force (EITaF) and supported by the German Infectious Disease Society. It aims at a better understanding of the implications of the new virus on patients by systematically documenting patient data across Europe (Text adapted from leoss.net). For more information please visit the official website. This document is for HIV-related baseline data. All questions refer to the day of diagnosis (diagnosis means first positive virus result). Please note that only cases with known outcome are collected at LEOSS! If a text field can't be filled out, note 'ND' (for not determined).

Lien

https://leoss.net

Mots-clés

Versions (3)
  1. 13/11/2020 13/11/2020 -
  2. 27/11/2020 27/11/2020 -
  3. 24/04/2021 24/04/2021 -
Détendeur de droits

LEOSS

Téléchargé le

27 novembre 2020

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    LEOSS: Lean European Open Survey on SARS-CoV-2 Infected Patients

    Anglais

    HIV-related baseline data

    1 Formulaires  
    HIV transmission risk
    Description

    HIV transmission risk

    Alias
    UMLS CUI-1
    C0019682
    UMLS CUI-2
    C0035648
    UMLS CUI-3
    C1443844
    Men having sex with men
    Description

    Men having sex with men

    Type de données

    integer

    Alias
    UMLS CUI [1]
    C2827413
    Heterosexual contacts
    Description

    Heterosexual contacts

    Type de données

    integer

    Alias
    UMLS CUI [1]
    C4272228
    Injection drug use
    Description

    Injection drug use

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C0281875
    UMLS CUI [1,2]
    C1272883
    UMLS CUI [2,1]
    C0086190
    UMLS CUI [2,2]
    C1272883
    Patient from an endemic area
    Description

    Patient from HIV endemic area

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C3258107
    UMLS CUI [1,2]
    C0277550
    UMLS CUI [1,3]
    C0019682
    Blood transfusion (excl. Haemophilia)
    Description

    Blood transfusion (excl. Haemophilia)

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C0005841
    UMLS CUI [1,2]
    C1705847
    UMLS CUI [1,3]
    C0684275
    Haemophilia
    Description

    Haemophilia

    Type de données

    integer

    Alias
    UMLS CUI [1]
    C0684275
    Other
    Description

    Other HIV transmission risk

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C0019682
    UMLS CUI [1,2]
    C0035648
    UMLS CUI [1,3]
    C1443844
    UMLS CUI [1,4]
    C0205394
    If Other, please specify:
    Description

    Other HIV transmission risk, specify

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C0019682
    UMLS CUI [1,2]
    C0035648
    UMLS CUI [1,3]
    C1443844
    UMLS CUI [1,4]
    C0205394
    UMLS CUI [1,5]
    C1521902
    Unknown
    Description

    Unknown HIV transmission risk

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C0439673
    UMLS CUI [1,2]
    C0035648
    UMLS CUI [1,3]
    C1443844
    UMLS CUI [1,4]
    C0205394
    Does the patient receive current antiretroviral therapy?
    Description

    Does the patient receive current antiretroviral therapy?

    Alias
    UMLS CUI-1
    C1963724
    UMLS CUI-2
    C0521116
    Protease Inhibitors (Lopinavir; Ritonavir; Darunavir; Atazanavir)
    Description

    Note: This question is critical for the further course of the questionnaire. Current in this context means at the time of first SARS-CoV-2 detection.

    Type de données

    integer

    Alias
    UMLS CUI [1]
    C0162714
    UMLS CUI [2]
    C0674432
    UMLS CUI [3]
    C0292818
    UMLS CUI [4]
    C1435444
    UMLS CUI [5]
    C1145759
    Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
    Description

    Note: This question is critical for the further course of the questionnaire. Current in this context means at the time of first SARS-CoV-2 detection.

    Type de données

    integer

    Alias
    UMLS CUI [1]
    C0376601
    UMLS CUI [2]
    C1871526
    UMLS CUI [3]
    C3253985
    UMLS CUI [4]
    C4507568
    UMLS CUI [5]
    C2606637
    Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
    Description

    Note: This question is critical for the further course of the questionnaire. Current in this context means at the time of first SARS-CoV-2 detection.

    Type de données

    integer

    Alias
    UMLS CUI [1]
    C3541376
    UMLS CUI [2]
    C0674428
    UMLS CUI [3]
    C0132326
    UMLS CUI [4]
    C1566826
    UMLS CUI [5]
    C4045491
    Nucleoside analog reverse-transcriptase inhibitors
    Description

    Note: This question is critical for the further course of the questionnaire. Current in this context means at the time of first SARS-CoV-2 detection.

    Type de données

    integer

    Alias
    UMLS CUI [1]
    C3537103
    Entry inhibitors (e.g. Maraviroc, Enfuvirtide)
    Description

    Note: This question is critical for the further course of the questionnaire. Current in this context means at the time of first SARS-CoV-2 detection.

    Type de données

    integer

    Alias
    UMLS CUI [1]
    C1449715
    UMLS CUI [2]
    C1667052
    UMLS CUI [3]
    C0537439
    In case of antiretroviral therapy for how long has antiretroviral therapy been taken before first positive SARS-CoV-2 testing?
    Description

    In case of antiretroviral therapy for how long has antiretroviral therapy been taken before first positive SARS-CoV-2 testing?

    Alias
    UMLS CUI-1
    C1963724
    UMLS CUI-2
    C0449238
    UMLS CUI-3
    C0332152
    UMLS CUI-4
    C5203676
    UMLS CUI-5
    C1511790
    In case of antiretroviral therapy for how long has antiretroviral therapy been taken before first positive SARS-CoV-2 testing?
    Description

    Note: This question is critical for the further course of the questionnaire. Please indicate the number of months antiretroviral therapy had been taken.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C1963724
    UMLS CUI [1,2]
    C0449238
    UMLS CUI [1,3]
    C0332152
    UMLS CUI [1,4]
    C5203676
    UMLS CUI [1,5]
    C1511790
    Has antiretroviral therapy been changed / been started during the course of SARS-Cov-2 infection?
    Description

    Has antiretroviral therapy been changed / been started during the course of SARS-Cov-2 infection?

    Alias
    UMLS CUI-1
    C1963724
    UMLS CUI-2
    C3665894
    UMLS CUI-3
    C1704686
    UMLS CUI-4
    C0347984
    UMLS CUI-5
    C5203670
    Has antiretroviral therapy been changed / been started during the course of SARS-Cov-2 infection?
    Description

    Note: This question is critical for the further course of the questionnaire.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C1963724
    UMLS CUI [1,2]
    C3665894
    UMLS CUI [1,3]
    C0347984
    UMLS CUI [1,4]
    C5203670
    UMLS CUI [2,1]
    C1963724
    UMLS CUI [2,2]
    C1704686
    UMLS CUI [2,3]
    C0347984
    UMLS CUI [2,4]
    C5203670
    Please indicate the regimen at the end of the follow-up period
    Description

    Please indicate the regimen at the end of the follow-up period

    Alias
    UMLS CUI-1
    C1963724
    UMLS CUI-2
    C1276413
    UMLS CUI-3
    C1522577
    UMLS CUI-4
    C0444930
    Protease Inhibitors (Lopinavir; Ritonavir; Darunavir; Atazanavir)
    Description

    Note: This question is critical for the further course of the questionnaire. In case no changes have been implemented, please name the original substances (as indicated in the question above).

    Type de données

    integer

    Alias
    UMLS CUI [1]
    C0162714
    UMLS CUI [2]
    C0674432
    UMLS CUI [3]
    C0292818
    UMLS CUI [4]
    C1435444
    UMLS CUI [5]
    C1145759
    Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
    Description

    Note: This question is critical for the further course of the questionnaire. In case no changes have been implemented, please name the original substances (as indicated in the question above).

    Type de données

    integer

    Alias
    UMLS CUI [1]
    C0376601
    UMLS CUI [2]
    C1871526
    UMLS CUI [3]
    C3253985
    UMLS CUI [4]
    C4507568
    UMLS CUI [5]
    C2606637
    Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
    Description

    Note: This question is critical for the further course of the questionnaire. In case no changes have been implemented, please name the original substances (as indicated in the question above).

    Type de données

    integer

    Alias
    UMLS CUI [1]
    C3541376
    UMLS CUI [2]
    C0674428
    UMLS CUI [3]
    C0132326
    UMLS CUI [4]
    C1566826
    UMLS CUI [5]
    C4045491
    Nucleoside analog reverse-transcriptase inhibitors
    Description

    Note: This question is critical for the further course of the questionnaire. In case no changes have been implemented, please name the original substances (as indicated in the question above).

    Type de données

    integer

    Alias
    UMLS CUI [1]
    C3537103
    Entry inhibitors (e.g. Maraviroc, Enfuvirtide)
    Description

    Note: This question is critical for the further course of the questionnaire. In case no changes have been implemented, please name the original substances (as indicated in the question above).

    Type de données

    integer

    Alias
    UMLS CUI [1]
    C1449715
    UMLS CUI [2]
    C1667052
    UMLS CUI [3]
    C0537439
    CD4+ T-cell count (abs.)
    Description

    CD4+ T-cell count (abs.)

    Alias
    UMLS CUI-1
    C1277776
    Before diagnosis
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C1277776
    UMLS CUI [1,2]
    C0332152
    UMLS CUI [1,3]
    C5203676
    UMLS CUI [1,4]
    C1511790
    Baseline (at first positive SARS-CoV-2 testing)
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C1277776
    UMLS CUI [1,2]
    C1442488
    UMLS CUI [2,1]
    C5203676
    UMLS CUI [2,2]
    C1511790
    Uncomplicated phase
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C1277776
    UMLS CUI [1,2]
    C0443334
    UMLS CUI [1,3]
    C0205390
    Complicated phase
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C1277776
    UMLS CUI [1,2]
    C0231242
    UMLS CUI [1,3]
    C0205390
    Critical phase
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C1277776
    UMLS CUI [1,2]
    C1511545
    UMLS CUI [1,3]
    C0205390
    Recovery phase
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C1277776
    UMLS CUI [1,2]
    C2004454
    UMLS CUI [1,3]
    C0205390
    CD4+ T-cell count (rel.)
    Description

    CD4+ T-cell count (rel.)

    Alias
    UMLS CUI-1
    C2698595
    UMLS CUI-2
    C0205345
    Before diagnosis
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C2698595
    UMLS CUI [1,2]
    C0205345
    UMLS CUI [1,3]
    C0332152
    UMLS CUI [1,4]
    C5203676
    UMLS CUI [1,5]
    C1511790
    Baseline (at first positive SARS-CoV-2 testing)
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C2698595
    UMLS CUI [1,2]
    C0205345
    UMLS CUI [1,3]
    C1442488
    UMLS CUI [2,1]
    C5203676
    UMLS CUI [2,2]
    C1511790
    Uncomplicated phase
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C2698595
    UMLS CUI [1,2]
    C0205345
    UMLS CUI [1,3]
    C0443334
    UMLS CUI [1,4]
    C0205390
    Complicated phase
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C2698595
    UMLS CUI [1,2]
    C0205345
    UMLS CUI [1,3]
    C0231242
    UMLS CUI [1,4]
    C0205390
    Critical phase
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C2698595
    UMLS CUI [1,2]
    C0205345
    UMLS CUI [1,3]
    C1511545
    UMLS CUI [1,4]
    C0205390
    Recovery phase
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C2698595
    UMLS CUI [1,2]
    C0205345
    UMLS CUI [1,3]
    C2004454
    UMLS CUI [1,4]
    C0205390
    Please indicate the CDC stage at baseline
    Description

    Please indicate the CDC stage at baseline

    Alias
    UMLS CUI-1
    C1272816
    Please indicate the CDC stage at baseline
    Description

    Note: This question is critical for the further course of the questionnaire. CDC stages are mainly defined by CD4 count (see figure on the following website), or stage-3-defining illness which can be revised at https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6303a1.htm?s_cid=rr6303a1_e

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C1272816
    UMLS CUI [1,2]
    C1442488
    CD8+ T-cell count (abs.)
    Description

    CD8+ T-cell count (abs.)

    Alias
    UMLS CUI-1
    C1277777
    Before diagnosis
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C1277777
    UMLS CUI [1,2]
    C0332152
    UMLS CUI [1,3]
    C5203676
    UMLS CUI [1,4]
    C1511790
    Baseline (at first positive SARS-CoV-2 testing)
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C1277777
    UMLS CUI [1,2]
    C1442488
    UMLS CUI [2,1]
    C5203676
    UMLS CUI [2,2]
    C1511790
    Uncomplicated phase
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C1277777
    UMLS CUI [1,2]
    C0443334
    UMLS CUI [1,3]
    C0205390
    Complicated phase
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C1277777
    UMLS CUI [1,2]
    C0231242
    UMLS CUI [1,3]
    C0205390
    Critical phase
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C1277777
    UMLS CUI [1,2]
    C1511545
    UMLS CUI [1,3]
    C0205390
    Recovery phase
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C1277777
    UMLS CUI [1,2]
    C2004454
    UMLS CUI [1,3]
    C0205390
    CD8+ T-cell count (rel.)
    Description

    CD8+ T-cell count (rel.)

    Alias
    UMLS CUI-1
    C2698600
    UMLS CUI-2
    C0205345
    Before diagnosis
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C2698600
    UMLS CUI [1,2]
    C0205345
    UMLS CUI [1,3]
    C0332152
    UMLS CUI [1,4]
    C5203676
    UMLS CUI [1,5]
    C1511790
    Baseline (at first positive SARS-CoV-2 testing)
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C2698600
    UMLS CUI [1,2]
    C0205345
    UMLS CUI [1,3]
    C1442488
    UMLS CUI [2,1]
    C5203676
    UMLS CUI [2,2]
    C1511790
    Uncomplicated phase
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C2698600
    UMLS CUI [1,2]
    C0205345
    UMLS CUI [1,3]
    C0443334
    UMLS CUI [1,4]
    C0205390
    Complicated phase
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C2698600
    UMLS CUI [1,2]
    C0205345
    UMLS CUI [1,3]
    C0231242
    UMLS CUI [1,4]
    C0205390
    Critical phase
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C2698600
    UMLS CUI [1,2]
    C0205345
    UMLS CUI [1,3]
    C1511545
    UMLS CUI [1,4]
    C0205390
    Recovery phase
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C2698600
    UMLS CUI [1,2]
    C0205345
    UMLS CUI [1,3]
    C2004454
    UMLS CUI [1,4]
    C0205390
    Viral load
    Description

    Viral load

    Alias
    UMLS CUI-1
    C1168369
    Before diagnosis
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C1168369
    UMLS CUI [1,2]
    C0332152
    UMLS CUI [1,3]
    C5203676
    UMLS CUI [1,4]
    C1511790
    Baseline (at first positive SARS-CoV-2 testing)
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C1168369
    UMLS CUI [1,2]
    C1442488
    UMLS CUI [2,1]
    C5203676
    UMLS CUI [2,2]
    C1511790
    Uncomplicated phase
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C1168369
    UMLS CUI [1,2]
    C0443334
    UMLS CUI [1,3]
    C0205390
    Complicated phase
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C1168369
    UMLS CUI [1,2]
    C0231242
    UMLS CUI [1,3]
    C0205390
    Critical phase
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C1168369
    UMLS CUI [1,2]
    C1511545
    UMLS CUI [1,3]
    C0205390
    Recovery phase
    Description

    Note: This question is critical for the further course of the questionnaire. For item 'before diagnosis' please indicate values as close to first positive SARS-CoV-2 testing as possible. If values were not determined within the last 6 months before diagnosis select not done. If no information is available select unknown. For the phases please indicate the lowest count during the whole phase.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C1168369
    UMLS CUI [1,2]
    C2004454
    UMLS CUI [1,3]
    C0205390
    Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection?
    Description

    Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection?

    Alias
    UMLS CUI-1
    C0029118
    UMLS CUI-2
    C0740830
    UMLS CUI-3
    C0036916
    UMLS CUI-4
    C5203670
    Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection?
    Description

    Note: This question is critical for the further course of the questionnaire.

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C0029118
    UMLS CUI [1,2]
    C5203670
    UMLS CUI [2,1]
    C0740830
    UMLS CUI [2,2]
    C5203670
    UMLS CUI [3,1]
    C0036916
    UMLS CUI [3,2]
    C5203670
    Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection? If Yes, please specify:
    Description

    Note: This question is critical for the further course of the questionnaire.

    Type de données

    text

    Alias
    UMLS CUI [1,1]
    C0029118
    UMLS CUI [1,2]
    C5203670
    UMLS CUI [2,1]
    C0740830
    UMLS CUI [2,2]
    C5203670
    UMLS CUI [3,1]
    C0036916
    UMLS CUI [3,2]
    C5203670
    UMLS CUI [4]
    C1521902
    Is data entry for this section finished?
    Description

    Is data entry for this section finished?

    Alias
    UMLS CUI-1
    C4684556
    UMLS CUI-2
    C1828479
    UMLS CUI-3
    C0205197
    Is data entry for this section finished?
    Description

    Is data entry for this section finished?

    Type de données

    integer

    Alias
    UMLS CUI [1,1]
    C4684556
    UMLS CUI [1,2]
    C1828479
    UMLS CUI [1,3]
    C0205197
    Retour au début de la page

    Similar models

    HIV-related baseline data

    1 Formulaires
    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    HIV transmission risk
    C0019682 (UMLS CUI-1)
    C0035648 (UMLS CUI-2)
    C1443844 (UMLS CUI-3)
    Item
    Men having sex with men
    integer
    C2827413 (UMLS CUI [1])
    Men having sex with men
    Code List
    Men having sex with men
    CL Item
    not quoted (0)
    CL Item
    quoted (1)
    Item
    Heterosexual contacts
    integer
    C4272228 (UMLS CUI [1])
    Men having sex with men
    Code List
    Heterosexual contacts
    CL Item
    not quoted (0)
    CL Item
    quoted (1)
    Item
    Injection drug use
    integer
    C0281875 (UMLS CUI [1,1])
    C1272883 (UMLS CUI [1,2])
    C0086190 (UMLS CUI [2,1])
    C1272883 (UMLS CUI [2,2])
    Men having sex with men
    Code List
    Injection drug use
    CL Item
    not quoted (0)
    CL Item
    quoted (1)
    Item
    Patient from an endemic area
    integer
    C3258107 (UMLS CUI [1,1])
    C0277550 (UMLS CUI [1,2])
    C0019682 (UMLS CUI [1,3])
    Men having sex with men
    Code List
    Patient from an endemic area
    CL Item
    not quoted (0)
    CL Item
    quoted (1)
    Item
    Blood transfusion (excl. Haemophilia)
    integer
    C0005841 (UMLS CUI [1,1])
    C1705847 (UMLS CUI [1,2])
    C0684275 (UMLS CUI [1,3])
    Men having sex with men
    Code List
    Blood transfusion (excl. Haemophilia)
    CL Item
    not quoted (0)
    CL Item
    quoted (1)
    Item
    Haemophilia
    integer
    C0684275 (UMLS CUI [1])
    Men having sex with men
    Code List
    Haemophilia
    CL Item
    not quoted (0)
    CL Item
    quoted (1)
    Item
    Other
    integer
    C0019682 (UMLS CUI [1,1])
    C0035648 (UMLS CUI [1,2])
    C1443844 (UMLS CUI [1,3])
    C0205394 (UMLS CUI [1,4])
    Men having sex with men
    Code List
    Other
    CL Item
    not quoted (0)
    CL Item
    quoted (1)
    Item
    If Other, please specify:
    integer
    C0019682 (UMLS CUI [1,1])
    C0035648 (UMLS CUI [1,2])
    C1443844 (UMLS CUI [1,3])
    C0205394 (UMLS CUI [1,4])
    C1521902 (UMLS CUI [1,5])
    Men having sex with men
    Code List
    If Other, please specify:
    CL Item
    not quoted (0)
    CL Item
    quoted (1)
    Item
    Unknown
    integer
    C0439673 (UMLS CUI [1,1])
    C0035648 (UMLS CUI [1,2])
    C1443844 (UMLS CUI [1,3])
    C0205394 (UMLS CUI [1,4])
    Men having sex with men
    Code List
    Unknown
    CL Item
    not quoted (0)
    CL Item
    quoted (1)
    Item Group
    Does the patient receive current antiretroviral therapy?
    C1963724 (UMLS CUI-1)
    C0521116 (UMLS CUI-2)
    Item
    Protease Inhibitors (Lopinavir; Ritonavir; Darunavir; Atazanavir)
    integer
    C0162714 (UMLS CUI [1])
    C0674432 (UMLS CUI [2])
    C0292818 (UMLS CUI [3])
    C1435444 (UMLS CUI [4])
    C1145759 (UMLS CUI [5])
    Gender
    Code List
    Protease Inhibitors (Lopinavir; Ritonavir; Darunavir; Atazanavir)
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
    integer
    C0376601 (UMLS CUI [1])
    C1871526 (UMLS CUI [2])
    C3253985 (UMLS CUI [3])
    C4507568 (UMLS CUI [4])
    C2606637 (UMLS CUI [5])
    Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
    Code List
    Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
    integer
    C3541376 (UMLS CUI [1])
    C0674428 (UMLS CUI [2])
    C0132326 (UMLS CUI [3])
    C1566826 (UMLS CUI [4])
    C4045491 (UMLS CUI [5])
    Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
    Code List
    Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Nucleoside analog reverse-transcriptase inhibitors
    integer
    C3537103 (UMLS CUI [1])
    Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
    Code List
    Nucleoside analog reverse-transcriptase inhibitors
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Entry inhibitors (e.g. Maraviroc, Enfuvirtide)
    integer
    C1449715 (UMLS CUI [1])
    C1667052 (UMLS CUI [2])
    C0537439 (UMLS CUI [3])
    Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
    Code List
    Entry inhibitors (e.g. Maraviroc, Enfuvirtide)
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    In case of antiretroviral therapy for how long has antiretroviral therapy been taken before first positive SARS-CoV-2 testing?
    C1963724 (UMLS CUI-1)
    C0449238 (UMLS CUI-2)
    C0332152 (UMLS CUI-3)
    C5203676 (UMLS CUI-4)
    C1511790 (UMLS CUI-5)
    Item
    In case of antiretroviral therapy for how long has antiretroviral therapy been taken before first positive SARS-CoV-2 testing?
    integer
    C1963724 (UMLS CUI [1,1])
    C0449238 (UMLS CUI [1,2])
    C0332152 (UMLS CUI [1,3])
    C5203676 (UMLS CUI [1,4])
    C1511790 (UMLS CUI [1,5])
    undefined item
    Code List
    In case of antiretroviral therapy for how long has antiretroviral therapy been taken before first positive SARS-CoV-2 testing?
    CL Item
    < 3 months (1)
    CL Item
    3 - 6 months (2)
    CL Item
    > 6 months (3)
    CL Item
    Unknown (4)
    CL Item
    No antiretroviral therapy (5)
    Item Group
    Has antiretroviral therapy been changed / been started during the course of SARS-Cov-2 infection?
    C1963724 (UMLS CUI-1)
    C3665894 (UMLS CUI-2)
    C1704686 (UMLS CUI-3)
    C0347984 (UMLS CUI-4)
    C5203670 (UMLS CUI-5)
    Item
    Has antiretroviral therapy been changed / been started during the course of SARS-Cov-2 infection?
    integer
    C1963724 (UMLS CUI [1,1])
    C3665894 (UMLS CUI [1,2])
    C0347984 (UMLS CUI [1,3])
    C5203670 (UMLS CUI [1,4])
    C1963724 (UMLS CUI [2,1])
    C1704686 (UMLS CUI [2,2])
    C0347984 (UMLS CUI [2,3])
    C5203670 (UMLS CUI [2,4])
    undefined item
    Code List
    Has antiretroviral therapy been changed / been started during the course of SARS-Cov-2 infection?
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    Please indicate the regimen at the end of the follow-up period
    C1963724 (UMLS CUI-1)
    C1276413 (UMLS CUI-2)
    C1522577 (UMLS CUI-3)
    C0444930 (UMLS CUI-4)
    Item
    Protease Inhibitors (Lopinavir; Ritonavir; Darunavir; Atazanavir)
    integer
    C0162714 (UMLS CUI [1])
    C0674432 (UMLS CUI [2])
    C0292818 (UMLS CUI [3])
    C1435444 (UMLS CUI [4])
    C1145759 (UMLS CUI [5])
    Gender
    Code List
    Protease Inhibitors (Lopinavir; Ritonavir; Darunavir; Atazanavir)
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
    integer
    C0376601 (UMLS CUI [1])
    C1871526 (UMLS CUI [2])
    C3253985 (UMLS CUI [3])
    C4507568 (UMLS CUI [4])
    C2606637 (UMLS CUI [5])
    Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
    Code List
    Integrase Inhibitors (Dolutegravir; Biktegravir; Raltegravir; Elvitegravir)
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
    integer
    C3541376 (UMLS CUI [1])
    C0674428 (UMLS CUI [2])
    C0132326 (UMLS CUI [3])
    C1566826 (UMLS CUI [4])
    C4045491 (UMLS CUI [5])
    Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
    Code List
    Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Nucleoside analog reverse-transcriptase inhibitors
    integer
    C3537103 (UMLS CUI [1])
    Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
    Code List
    Nucleoside analog reverse-transcriptase inhibitors
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item
    Entry inhibitors (e.g. Maraviroc, Enfuvirtide)
    integer
    C1449715 (UMLS CUI [1])
    C1667052 (UMLS CUI [2])
    C0537439 (UMLS CUI [3])
    Non-nucleoside reverse-transcriptase inhibitors (Efavirenz; Nevirapin; Rilpivirin; Doravirin)
    Code List
    Entry inhibitors (e.g. Maraviroc, Enfuvirtide)
    CL Item
    Yes (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Item Group
    CD4+ T-cell count (abs.)
    C1277776 (UMLS CUI-1)
    Item
    Before diagnosis
    integer
    C1277776 (UMLS CUI [1,1])
    C0332152 (UMLS CUI [1,2])
    C5203676 (UMLS CUI [1,3])
    C1511790 (UMLS CUI [1,4])
    Before SARS-CoV-2 detection
    Code List
    Before diagnosis
    CL Item
    < 200 Cells / µL (1)
    CL Item
    200-500 Cells / µL (2)
    CL Item
    > 500 Cells / µL (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item
    Baseline (at first positive SARS-CoV-2 testing)
    integer
    C1277776 (UMLS CUI [1,1])
    C1442488 (UMLS CUI [1,2])
    C5203676 (UMLS CUI [2,1])
    C1511790 (UMLS CUI [2,2])
    Before SARS-CoV-2 detection
    Code List
    Baseline (at first positive SARS-CoV-2 testing)
    CL Item
    < 200 Cells / µL (1)
    CL Item
    200-500 Cells / µL (2)
    CL Item
    > 500 Cells / µL (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item
    Uncomplicated phase
    integer
    C1277776 (UMLS CUI [1,1])
    C0443334 (UMLS CUI [1,2])
    C0205390 (UMLS CUI [1,3])
    Before SARS-CoV-2 detection
    Code List
    Uncomplicated phase
    CL Item
    < 200 Cells / µL (1)
    CL Item
    200-500 Cells / µL (2)
    CL Item
    > 500 Cells / µL (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item
    Complicated phase
    integer
    C1277776 (UMLS CUI [1,1])
    C0231242 (UMLS CUI [1,2])
    C0205390 (UMLS CUI [1,3])
    Before SARS-CoV-2 detection
    Code List
    Complicated phase
    CL Item
    < 200 Cells / µL (1)
    CL Item
    200-500 Cells / µL (2)
    CL Item
    > 500 Cells / µL (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item
    Critical phase
    integer
    C1277776 (UMLS CUI [1,1])
    C1511545 (UMLS CUI [1,2])
    C0205390 (UMLS CUI [1,3])
    Before SARS-CoV-2 detection
    Code List
    Critical phase
    CL Item
    < 200 Cells / µL (1)
    CL Item
    200-500 Cells / µL (2)
    CL Item
    > 500 Cells / µL (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item
    Recovery phase
    integer
    C1277776 (UMLS CUI [1,1])
    C2004454 (UMLS CUI [1,2])
    C0205390 (UMLS CUI [1,3])
    Before SARS-CoV-2 detection
    Code List
    Recovery phase
    CL Item
    < 200 Cells / µL (1)
    CL Item
    200-500 Cells / µL (2)
    CL Item
    > 500 Cells / µL (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item Group
    CD4+ T-cell count (rel.)
    C2698595 (UMLS CUI-1)
    C0205345 (UMLS CUI-2)
    Item
    Before diagnosis
    integer
    C2698595 (UMLS CUI [1,1])
    C0205345 (UMLS CUI [1,2])
    C0332152 (UMLS CUI [1,3])
    C5203676 (UMLS CUI [1,4])
    C1511790 (UMLS CUI [1,5])
    Before SARS-CoV-2 detection
    Code List
    Before diagnosis
    CL Item
    < 14 % (1)
    CL Item
    14 - 25 % (2)
    CL Item
    > 25 % (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item
    Baseline (at first positive SARS-CoV-2 testing)
    integer
    C2698595 (UMLS CUI [1,1])
    C0205345 (UMLS CUI [1,2])
    C1442488 (UMLS CUI [1,3])
    C5203676 (UMLS CUI [2,1])
    C1511790 (UMLS CUI [2,2])
    Before SARS-CoV-2 detection
    Code List
    Baseline (at first positive SARS-CoV-2 testing)
    CL Item
    < 14 % (1)
    CL Item
    14 - 25 % (2)
    CL Item
    > 25 % (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item
    Uncomplicated phase
    integer
    C2698595 (UMLS CUI [1,1])
    C0205345 (UMLS CUI [1,2])
    C0443334 (UMLS CUI [1,3])
    C0205390 (UMLS CUI [1,4])
    Before SARS-CoV-2 detection
    Code List
    Uncomplicated phase
    CL Item
    < 14 % (1)
    CL Item
    14 - 25 % (2)
    CL Item
    > 25 % (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item
    Complicated phase
    integer
    C2698595 (UMLS CUI [1,1])
    C0205345 (UMLS CUI [1,2])
    C0231242 (UMLS CUI [1,3])
    C0205390 (UMLS CUI [1,4])
    Before SARS-CoV-2 detection
    Code List
    Complicated phase
    CL Item
    < 14 % (1)
    CL Item
    14 - 25 % (2)
    CL Item
    > 25 % (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item
    Critical phase
    integer
    C2698595 (UMLS CUI [1,1])
    C0205345 (UMLS CUI [1,2])
    C1511545 (UMLS CUI [1,3])
    C0205390 (UMLS CUI [1,4])
    Before SARS-CoV-2 detection
    Code List
    Critical phase
    CL Item
    < 14 % (1)
    CL Item
    14 - 25 % (2)
    CL Item
    > 25 % (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item
    Recovery phase
    integer
    C2698595 (UMLS CUI [1,1])
    C0205345 (UMLS CUI [1,2])
    C2004454 (UMLS CUI [1,3])
    C0205390 (UMLS CUI [1,4])
    Before SARS-CoV-2 detection
    Code List
    Recovery phase
    CL Item
    < 14 % (1)
    CL Item
    14 - 25 % (2)
    CL Item
    > 25 % (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item Group
    Please indicate the CDC stage at baseline
    C1272816 (UMLS CUI-1)
    Item
    Please indicate the CDC stage at baseline
    integer
    C1272816 (UMLS CUI [1,1])
    C1442488 (UMLS CUI [1,2])
    HIV CDC stage at baseline
    Code List
    Please indicate the CDC stage at baseline
    CL Item
    Stage 1 (1)
    CL Item
    Stage 2 (2)
    CL Item
    Stage 3 (3)
    CL Item
    Unknown (4)
    Item Group
    CD8+ T-cell count (abs.)
    C1277777 (UMLS CUI-1)
    Item
    Before diagnosis
    integer
    C1277777 (UMLS CUI [1,1])
    C0332152 (UMLS CUI [1,2])
    C5203676 (UMLS CUI [1,3])
    C1511790 (UMLS CUI [1,4])
    CD8+ (abs): Before SARS-CoV-2 detection
    Code List
    Before diagnosis
    CL Item
    < 250 cells / μl (1)
    CL Item
    250 - 1000 cells / μl (2)
    CL Item
    > 1000 cells / μl (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item
    Baseline (at first positive SARS-CoV-2 testing)
    integer
    C1277777 (UMLS CUI [1,1])
    C1442488 (UMLS CUI [1,2])
    C5203676 (UMLS CUI [2,1])
    C1511790 (UMLS CUI [2,2])
    CD8+ (abs): Baseline (at SARS-CoV-2 detection)
    Code List
    Baseline (at first positive SARS-CoV-2 testing)
    CL Item
    < 250 cells / μl (1)
    CL Item
    250 - 1000 cells / μl (2)
    CL Item
    > 1000 cells / μl (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item
    Uncomplicated phase
    integer
    C1277777 (UMLS CUI [1,1])
    C0443334 (UMLS CUI [1,2])
    C0205390 (UMLS CUI [1,3])
    CD8+ (abs): Uncomplicated phase
    Code List
    Uncomplicated phase
    CL Item
    < 250 cells / μl (1)
    CL Item
    250 - 1000 cells / μl (2)
    CL Item
    > 1000 cells / μl (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item
    Complicated phase
    integer
    C1277777 (UMLS CUI [1,1])
    C0231242 (UMLS CUI [1,2])
    C0205390 (UMLS CUI [1,3])
    CD8+ (abs): Complicated phase
    Code List
    Complicated phase
    CL Item
    < 250 cells / μl (1)
    CL Item
    250 - 1000 cells / μl (2)
    CL Item
    > 1000 cells / μl (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item
    Critical phase
    integer
    C1277777 (UMLS CUI [1,1])
    C1511545 (UMLS CUI [1,2])
    C0205390 (UMLS CUI [1,3])
    CD8+ (abs): Critical phase
    Code List
    Critical phase
    CL Item
    < 250 cells / μl (1)
    CL Item
    250 - 1000 cells / μl (2)
    CL Item
    > 1000 cells / μl (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item
    Recovery phase
    integer
    C1277777 (UMLS CUI [1,1])
    C2004454 (UMLS CUI [1,2])
    C0205390 (UMLS CUI [1,3])
    CD8+ (abs): Recovery phase
    Code List
    Recovery phase
    CL Item
    < 250 cells / μl (1)
    CL Item
    250 - 1000 cells / μl (2)
    CL Item
    > 1000 cells / μl (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item Group
    CD8+ T-cell count (rel.)
    C2698600 (UMLS CUI-1)
    C0205345 (UMLS CUI-2)
    Item
    Before diagnosis
    integer
    C2698600 (UMLS CUI [1,1])
    C0205345 (UMLS CUI [1,2])
    C0332152 (UMLS CUI [1,3])
    C5203676 (UMLS CUI [1,4])
    C1511790 (UMLS CUI [1,5])
    CD8+ (rel): Before SARS-CoV-2 detection
    Code List
    Before diagnosis
    CL Item
    < 15 % (1)
    CL Item
    15 - 40 % (2)
    CL Item
    > 40 %  (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item
    Baseline (at first positive SARS-CoV-2 testing)
    integer
    C2698600 (UMLS CUI [1,1])
    C0205345 (UMLS CUI [1,2])
    C1442488 (UMLS CUI [1,3])
    C5203676 (UMLS CUI [2,1])
    C1511790 (UMLS CUI [2,2])
    CD8+ (rel): Baseline (at SARS-CoV-2 detection)
    Code List
    Baseline (at first positive SARS-CoV-2 testing)
    CL Item
    < 15 % (1)
    CL Item
    15 - 40 % (2)
    CL Item
    > 40 %  (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item
    Uncomplicated phase
    integer
    C2698600 (UMLS CUI [1,1])
    C0205345 (UMLS CUI [1,2])
    C0443334 (UMLS CUI [1,3])
    C0205390 (UMLS CUI [1,4])
    CD8+ (rel): Uncomplicated phase
    Code List
    Uncomplicated phase
    CL Item
    < 15 % (1)
    CL Item
    15 - 40 % (2)
    CL Item
    > 40 %  (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item
    Complicated phase
    integer
    C2698600 (UMLS CUI [1,1])
    C0205345 (UMLS CUI [1,2])
    C0231242 (UMLS CUI [1,3])
    C0205390 (UMLS CUI [1,4])
    CD8+ (rel): Complicated phase
    Code List
    Complicated phase
    CL Item
    < 15 % (1)
    CL Item
    15 - 40 % (2)
    CL Item
    > 40 %  (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item
    Critical phase
    integer
    C2698600 (UMLS CUI [1,1])
    C0205345 (UMLS CUI [1,2])
    C1511545 (UMLS CUI [1,3])
    C0205390 (UMLS CUI [1,4])
    CD8+ (rel): Critical phase
    Code List
    Critical phase
    CL Item
    < 15 % (1)
    CL Item
    15 - 40 % (2)
    CL Item
    > 40 %  (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item
    Recovery phase
    integer
    C2698600 (UMLS CUI [1,1])
    C0205345 (UMLS CUI [1,2])
    C2004454 (UMLS CUI [1,3])
    C0205390 (UMLS CUI [1,4])
    CD8+ (rel): Recovery phase
    Code List
    Recovery phase
    CL Item
    < 15 % (1)
    CL Item
    15 - 40 % (2)
    CL Item
    > 40 %  (3)
    CL Item
    Unknown (4)
    CL Item
    Not done (5)
    Item Group
    Viral load
    C1168369 (UMLS CUI-1)
    Item
    Before diagnosis
    integer
    C1168369 (UMLS CUI [1,1])
    C0332152 (UMLS CUI [1,2])
    C5203676 (UMLS CUI [1,3])
    C1511790 (UMLS CUI [1,4])
    CD8+ (rel): Before SARS-CoV-2 detection
    Code List
    Before diagnosis
    CL Item
    < 50 copies / ml (1)
    CL Item
    >= 50 copies / ml (2)
    CL Item
    Unknown (3)
    CL Item
    Not done (4)
    Item
    Baseline (at first positive SARS-CoV-2 testing)
    integer
    C1168369 (UMLS CUI [1,1])
    C1442488 (UMLS CUI [1,2])
    C5203676 (UMLS CUI [2,1])
    C1511790 (UMLS CUI [2,2])
    CD8+ (rel): Baseline (at SARS-CoV-2 detection)
    Code List
    Baseline (at first positive SARS-CoV-2 testing)
    CL Item
    < 50 copies / ml (1)
    CL Item
    >= 50 copies / ml (2)
    CL Item
    Unknown (3)
    CL Item
    Not done (4)
    Item
    Uncomplicated phase
    integer
    C1168369 (UMLS CUI [1,1])
    C0443334 (UMLS CUI [1,2])
    C0205390 (UMLS CUI [1,3])
    CD8+ (rel): Uncomplicated phase
    Code List
    Uncomplicated phase
    CL Item
    < 50 copies / ml (1)
    CL Item
    >= 50 copies / ml (2)
    CL Item
    Unknown (3)
    CL Item
    Not done (4)
    Item
    Complicated phase
    integer
    C1168369 (UMLS CUI [1,1])
    C0231242 (UMLS CUI [1,2])
    C0205390 (UMLS CUI [1,3])
    CD8+ (rel): Complicated phase
    Code List
    Complicated phase
    CL Item
    < 50 copies / ml (1)
    CL Item
    >= 50 copies / ml (2)
    CL Item
    Unknown (3)
    CL Item
    Not done (4)
    Item
    Critical phase
    integer
    C1168369 (UMLS CUI [1,1])
    C1511545 (UMLS CUI [1,2])
    C0205390 (UMLS CUI [1,3])
    CD8+ (rel): Critical phase
    Code List
    Critical phase
    CL Item
    < 50 copies / ml (1)
    CL Item
    >= 50 copies / ml (2)
    CL Item
    Unknown (3)
    CL Item
    Not done (4)
    Item
    Recovery phase
    integer
    C1168369 (UMLS CUI [1,1])
    C2004454 (UMLS CUI [1,2])
    C0205390 (UMLS CUI [1,3])
    CD8+ (rel): Recovery phase
    Code List
    Recovery phase
    CL Item
    < 50 copies / ml (1)
    CL Item
    >= 50 copies / ml (2)
    CL Item
    Unknown (3)
    CL Item
    Not done (4)
    Item Group
    Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection?
    C0029118 (UMLS CUI-1)
    C0740830 (UMLS CUI-2)
    C0036916 (UMLS CUI-3)
    C5203670 (UMLS CUI-4)
    Item
    Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection?
    integer
    C0029118 (UMLS CUI [1,1])
    C5203670 (UMLS CUI [1,2])
    C0740830 (UMLS CUI [2,1])
    C5203670 (UMLS CUI [2,2])
    C0036916 (UMLS CUI [3,1])
    C5203670 (UMLS CUI [3,2])
    Opportunistic infections, AIDS-defining illnesses, STI during SARS-CoV-2
    Code List
    Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection?
    CL Item
    Yes, please sepcify (1)
    CL Item
    No (2)
    CL Item
    Unknown (3)
    Opportunistic infections, AIDS-defining illnesses, STI during COVID-19 - specify
    Item
    Did any opportunistic infections, AIDS-defining illnesses or STI (sexually transmitted infection) occur during SARS-CoV-2 infection? If Yes, please specify:
    text
    C0029118 (UMLS CUI [1,1])
    C5203670 (UMLS CUI [1,2])
    C0740830 (UMLS CUI [2,1])
    C5203670 (UMLS CUI [2,2])
    C0036916 (UMLS CUI [3,1])
    C5203670 (UMLS CUI [3,2])
    C1521902 (UMLS CUI [4])
    Item Group
    Is data entry for this section finished?
    C4684556 (UMLS CUI-1)
    C1828479 (UMLS CUI-2)
    C0205197 (UMLS CUI-3)
    Item
    Is data entry for this section finished?
    integer
    C4684556 (UMLS CUI [1,1])
    C1828479 (UMLS CUI [1,2])
    C0205197 (UMLS CUI [1,3])
    BL_Completed
    Code List
    Is data entry for this section finished?
    CL Item
    Yes (1)
    CL Item
    No (2)
    Retour au début de la page 

    Aide

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial